COPD — all decisions

The appeal for service connection for sinusitis was withdrawn by the Veteran, and the claim for COPD was denied due to a lack of evidence showing a current diagnosis.

The Board denied service connection for chronic obstructive pulmonary disease (COPD) as the evidence did not support a nexus between the condition and the Veteran's service, specifically due to his long history of smoking.

The Board has remanded the claims for service connection for benign prostatic hypertrophy, chronic obstructive pulmonary disease (COPD), and right kidney cancer, removed, to obtain additional evidence.

The Board granted service connection for kidney cancer and COPD, both secondary to the Veteran's service-connected psoriatic arthritis.

The Board remands the Veteran's claim for service connection for chronic obstructive pulmonary disease (COPD) to correct a pre-decisional error in satisfying VA's duty to assist by obtaining an adequate medical opinion regarding the etiology of the condition, including whether it is related to burn pit exposure during active service.

The Board denied service connection for chronic obstructive pulmonary disease, respiratory condition, and erectile dysfunction as they are not related to the Veteran's in-service exposure to herbicide agents.

The Board granted an initial rating of 70 percent for PTSD and a total disability rating based on individual unemployability (TDIU), while remanding the claims for service connection for obstructive sleep apnea and chronic obstructive pulmonary disease.

The Board dismissed the veteran's claims for service connection for chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA) due to a formal defect in the appeal process.

The Board remands the claim for service connection for the cause of the Veteran's death to obtain a more comprehensive VA medical opinion regarding the relationship between the Veteran's in-service exposure to herbicide agents and his causes of death.

The Board remands the matter for further development, including obtaining additional service records and medical opinions to address the Veteran's alleged exposure to asbestos and the aggravation of his pre-existing conditions during service.

The claims for service connection for chronic obstructive pulmonary disease and right leg condition are remanded due to the RO's failure to substantially comply with the Board's prior remand instructions.

The Board remands the claim for a respiratory condition, to include restrictive lung disease and COPD, as an addendum opinion is needed regarding direct service connection.

The Veteran's ACD, COPD, bronchitis, and emphysema were granted service connection with a rating of 60 percent for ACD effective July 27, 2021.

The Board granted service connection for asthma and COPD, finding that the Veteran's conditions were directly related to his exposure to toxins during active service in Vietnam.

The Board remands the claims for service connection for chronic obstructive pulmonary disease and sleep apnea to obtain further development, including a VA examination and medical nexus opinion.

The Board denied the veteran's claims for increased ratings and service connection, as well as remanded several issues for further development.

The Board remands the Veteran's claim for service connection for chronic obstructive pulmonary disease to obtain a medical nexus opinion regarding its etiology, particularly in relation to conceded in-service toxic exposures.

The Board denied service connection for COPD, bilateral hearing loss, OSA, atrial fibrillation, and tinnitus. The Board also denied increased ratings for lumbar strain with lumbar spondylosis, left lower extremity (LLE) radiculopathy, right lower extremity (RLE) radiculopathy, and hypertension.

The Board remands the issues of entitlement to a higher disability rating and an earlier effective date for service-connected COPD and obstructive sleep apnea due to inextricably intertwined claims.

The Board denied the veteran's claim for a compensable disability rating for chronic obstructive pulmonary disease (COPD) as the evidence did not support a higher rating.